Home LiteratureArticle Details
PMID: 11313013 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Dissecting the host response to a gamma-herpesvirus.

Doherty PC, Christensen JP, Belz GT, Stevenson PG, Sangster MY

Abstract

The murine gamma-herpesvirus 68 (MHV-68) provides a unique experimental model for dissecting immunity to large DNA viruses that persist in B lymphocytes. The analysis is greatly facilitated by the availability of genetically disrupted (-/-) mice that lack key host-response elements, and by the fact that MHV-68 is a lytic virus that can readily be manipulated for mutational analysis. The mutant virus strategy is being used, for example, to characterize the part played in vivo by an MHV-68-encoded chemokine-binding protein that may ultimately find an application in human therapeutics. Experiments with various -/- mice and monoclonal antibody depletion protocols have shown very clearly that type I interferons (IFNs) are essential for the early control of MHV-68 replication, while CD4+ T cells producing IFN-gamma function to limit the consequences of viral persistence. Virus-specific CD8+ effectors acting in the absence of the CD4+ subset seem initially to control the lytic phase in the lung following respiratory challenge, but are then unable to prevent the reactivation of replicative infection in epithelia and the eventual death of CD4+ T-cell-deficient mice. This could reflect the fact that the interaction between the CD8+ T cells and the virus-infected targets is partially compromised by the MHV-68 K3 protein, which inhibits antigen presentation by MHC class I glycoproteins. Immunization strategies focusing on the CD8+ T-cell response to epitopes expressed during the lytic phase of MHV-68 infection can limit virus replication, but are unable to prevent the establishment of latency. Other experiments with mutant viruses also suggest that there is a disconnection between lytic MHV-68 infection and latency. The massive nonspecific immunoglobulin response and the dramatic expansion of Vbeta4+ CD8+ T cells, which is apparently MHC independent, could represent some sort of 'smoke screen' used by MHV-68 to subvert immunity. Although MHV-68 is neither Epstein-Barr virus nor human herpesvirus-8, the results generated from this system suggest possibilities that may usefully be addressed with these human pathogens. Perhaps the main lesson learned to date is that all the components of immunity are likely to be important for the control of these complex viruses.

MeSH Terms
Animals B-Lymphocytes/immunology CD4-Positive T-Lymphocytes/immunology CD8-Positive T-Lymphocytes/immunology Chemokines/immunology Cytokines/immunology Gammaherpesvirinae/immunology Herpesviridae Infections/immunology,pathology,prevention & control,virology Humans Immunization Tumor Virus Infections/immunology,pathology,prevention & control,virology
Chemicals
Chemokines Cytokines
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Doherty P C
Department of Immunology, St Jude Children's Research Hospital, Memphis, TN 38105, USA. [email protected]
Christensen J P
Belz G T
Stevenson P G
Sangster M Y
References (111)
111 references, click to expand
  1. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.
    Immunity. 1998 Feb;8(2):177-87 PMID: 9491999
  2. The numbers game for virus-specific CD8+ T cells.
    Science. 1998 Apr 10;280(5361):227 PMID: 9565533
  3. A new look at T cells.
    J Exp Med. 1998 May 4;187(9):1367-71 PMID: 9565629
  4. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo.
    J Exp Med. 1998 May 4;187(9):1395-402 PMID: 9565632
  5. Lung epithelial cells are a major site of murine gammaherpesvirus persistence.
    J Exp Med. 1998 Jun 15;187(12):1941-51 PMID: 9625754
  6. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels.
    J Exp Med. 1998 Aug 3;188(3):577-88 PMID: 9687534
  7. Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis.
    Trends Microbiol. 1998 Jul;6(7):276-82 PMID: 9717216
  8. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection.
    J Exp Med. 1998 Sep 21;188(6):1047-54 PMID: 9743523
  9. The murine gammaherpesvirus-68 M11 protein inhibits Fas- and TNF-induced apoptosis.
    J Gen Virol. 1999 Oct;80 ( Pt 10):2737-40 PMID: 10573168
  10. Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication.
    Virology. 2000 Jan 5;266(1):17-25 PMID: 10612656
  11. Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates?
    J Virol. 2000 Feb;74(3):1572-7 PMID: 10627572
  12. Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency.
    J Virol. 2000 Feb;74(4):1973-84 PMID: 10644370
  13. Infection of intestinal epithelial cells and development of systemic disease following gastric instillation of murine gammaherpesvirus-68.
    J Gen Virol. 2000 Feb;81(Pt 2):421-9 PMID: 10644841
  14. Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus.
    J Immunol. 2000 Feb 15;164(4):1820-8 PMID: 10657630
  15. Transmission of ovine herpesvirus 2 among adult sheep.
    Vet Microbiol. 2000 Jan;71(1-2):27-35 PMID: 10665531
  16. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus.
    J Exp Med. 2000 Feb 7;191(3):573-8 PMID: 10662803
  17. Lymphotoxin-alpha-deficient mice can clear a productive infection with murine gammaherpesvirus 68 but fail to develop splenomegaly or lymphocytosis.
    J Virol. 2000 Mar;74(6):2786-92 PMID: 10684295
  18. The primary sequence of rhesus monkey rhadinovirus isolate 26-95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577.
    J Virol. 2000 Apr;74(7):3388-98 PMID: 10708456
  19. Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice.
    Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2725-30 PMID: 10694575
  20. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice.
    J Virol. 2000 May;74(9):3996-4003 PMID: 10756011
  21. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins.
    J Virol. 2000 Jun;74(11):5300-9 PMID: 10799607
  22. Accessing complexity: the dynamics of virus-specific T cell responses.
    Annu Rev Immunol. 2000;18:561-92 PMID: 10837069
  23. Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia.
    J Exp Med. 2000 Jun 5;191(11):1853-67 PMID: 10839802
  24. Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I.
    J Immunol. 2000 Jun 15;164(12):6474-9 PMID: 10843704
  25. T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice.
    J Virol. 1999 Dec;73(12):9849-57 PMID: 10559297
  26. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis.
    Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8051-6 PMID: 10859362
  27. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses.
    Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8455-60 PMID: 10890918
  28. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
    J Virol. 2000 Aug;74(16):7485-95 PMID: 10906202
  29. Murine gamma-herpesvirus infection causes V(beta)4-specific CDR3-restricted clonal expansions within CD8(+) peripheral blood T lymphocytes.
    Int Immunol. 2000 Aug;12(8):1193-204 PMID: 10917894
  30. Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells.
    J Exp Med. 2000 Oct 2;192(7):943-52 PMID: 11015436
  31. Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory.
    J Virol. 2000 Dec;74(24):11690-6 PMID: 11090168
  32. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.
    Proc Natl Acad Sci U S A. 1968 Jan;59(1):94-101 PMID: 5242134
  33. The attenuation of a herpes virus (malignant catarrhal fever virus) isolated from hartebeest (Alcelaphus buselaphus cokei Gunther).
    Res Vet Sci. 1973 Jul;15(1):144-6 PMID: 4778485
  34. Isolation of five strains of herpesviruses from two species of free living small rodents.
    Acta Virol. 1980 Dec;24(6):468 PMID: 6111210
  35. Vaccination against Epstein-Barr virus: current progress and future strategies.
    Lancet. 1986 Jun 21;1(8495):1425-7 PMID: 2872525
  36. Conservation of gene organization in the lymphotropic herpesviruses herpesvirus Saimiri and Epstein-Barr virus.
    J Virol. 1988 Mar;62(3):757-67 PMID: 2828671
  37. The pathology of wildebeest-associated malignant catarrhal fever in hamsters, rats and guinea-pigs.
    J Comp Pathol. 1988 Jan;98(1):99-109 PMID: 3346394
  38. Prevention of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes.
    J Gen Virol. 1988 Aug;69 ( Pt 8):2093-6 PMID: 2841417
  39. Malignant catarrhal fever in a roan antelope (Hippotragus equinus) at Regent's Park.
    Vet Rec. 1989 Jan 14;124(2):42-3 PMID: 2916315
  40. Cloning and molecular characterization of the murine herpesvirus 68 genome.
    J Gen Virol. 1990 Jun;71 ( Pt 6):1355-64 PMID: 2351958
  41. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.
    Nature. 1991 Apr 4;350(6317):423-6 PMID: 1901381
  42. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast.
    J Exp Med. 1991 Aug 1;174(2):425-34 PMID: 1713253
  43. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice.
    Science. 1991 Sep 20;253(5026):1417-20 PMID: 1910207
  44. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands.
    J Virol. 1992 Apr;66(4):1977-84 PMID: 1312614
  45. Roles of alpha beta and gamma delta T cell subsets in viral immunity.
    Annu Rev Immunol. 1992;10:123-51 PMID: 1534240
  46. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo.
    J Gen Virol. 1992 Dec;73 ( Pt 12):3275-9 PMID: 1469366
  47. Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells.
    J Virol. 1993 Sep;67(9):5247-52 PMID: 8394447
  48. Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination.
    Vaccine. 1999 Jan;17(2):152-7 PMID: 9987149
  49. Immunological control of a murine gammaherpesvirus independent of CD8+ T cells.
    J Gen Virol. 1999 Feb;80 ( Pt 2):477-83 PMID: 10073710
  50. The major Epstein-Barr virus (EBV) envelope glycoprotein gp340 when incorporated into Iscoms primes cytotoxic T-cell responses directed against EBV lymphoblastoid cell lines.
    Vaccine. 1999 Mar 5;17(9-10):1282-90 PMID: 10195641
  51. Quantitative analysis of the acute and long-term CD4(+) T-cell response to a persistent gammaherpesvirus.
    J Virol. 1999 May;73(5):4279-83 PMID: 10196325
  52. Identification and initial characterization of the murine gammaherpesvirus 68 gene M3, encoding an abundantly secreted protein.
    J Virol. 1999 May;73(5):4524-9 PMID: 10196360
  53. Detection of two novel porcine herpesviruses with high similarity to gammaherpesviruses.
    J Gen Virol. 1999 Apr;80 ( Pt 4):971-8 PMID: 10211967
  54. CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma.
    Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5135-40 PMID: 10220431
  55. Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection.
    Eur J Immunol. 1999 Apr;29(4):1059-67 PMID: 10229071
  56. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys.
    J Immunol. 1999 May 1;162(9):5127-33 PMID: 10227983
  57. The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes.
    J Virol. 1999 Jun;73(6):5110-22 PMID: 10233974
  58. Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes.
    Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7508-13 PMID: 10377445
  59. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection.
    J Immunol. 1999 Jul 15;163(2):868-74 PMID: 10395681
  60. Apparent MHC-independent stimulation of CD8+ T cells in vivo during latent murine gammaherpesvirus infection.
    J Immunol. 1999 Aug 1;163(3):1481-9 PMID: 10415050
  61. A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope.
    Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9281-6 PMID: 10430934
  62. Murine gammaherpesvirus 68 encodes a functional regulator of complement activation.
    J Virol. 1999 Sep;73(9):7658-70 PMID: 10438856
  63. Turnover of T cells in murine gammaherpesvirus 68-infected mice.
    J Virol. 1999 Sep;73(9):7866-9 PMID: 10438881
  64. Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection.
    Curr Opin Immunol. 1999 Aug;11(4):371-9 PMID: 10448140
  65. Host and viral genetics of chronic infection: a mouse model of gamma-herpesvirus pathogenesis.
    Curr Opin Microbiol. 1999 Aug;2(4):403-9 PMID: 10458986
  66. Identification, sequence analysis and characterisation of equine herpesvirus 5 glycoprotein B.
    Arch Virol. 1999;144(2):287-307 PMID: 10470254
  67. Newly recognized herpesvirus causing malignant catarrhal fever in white-tailed deer (Odocoileus virginianus).
    J Clin Microbiol. 2000 Apr;38(4):1313-8 PMID: 10747100
  68. Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection.
    Virology. 1999 Sep 1;261(2):173-9 PMID: 10497103
  69. Requirement for CD40 ligand, CD4(+) T cells, and B cells in an infectious mononucleosis-like syndrome.
    J Virol. 1999 Nov;73(11):9650-4 PMID: 10516078
  70. Requirement for CD4+ T cells in V beta 4+CD8+ T cell activation associated with latent murine gammaherpesvirus infection.
    J Immunol. 1999 Sep 15;163(6):3403-8 PMID: 10477611
  71. Persistence of memory CD8 T cells in MHC class I-deficient mice.
    Science. 1999 Nov 12;286(5443):1377-81 PMID: 10558996
  72. Kinetic and phenotypic changes in murine lymphocytes infected with murine gammaherpesvirus-68 in vitro.
    J Gen Virol. 1999 Oct;80 ( Pt 10):2729-36 PMID: 10573167
  73. Superantigens: bacterial and viral proteins that manipulate the immune system.
    Annu Rev Cell Biol. 1993;9:101-28 PMID: 7506550
  74. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
    Virology. 1994 Jul;202(1):76-88 PMID: 7912023
  75. Respiratory virus infection of mice provokes a permanent humoral immune response.
    J Virol. 1994 Sep;68(9):6083-6 PMID: 8057487
  76. The role of CD4+ T cells in cell-mediated immunity to LCMV: studies in MHC class I and class II deficient mice.
    Scand J Immunol. 1994 Oct;40(4):373-82 PMID: 7939408
  77. Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68.
    Am J Pathol. 1994 Oct;145(4):818-26 PMID: 7943173
  78. Interactions of the murine gammaherpesvirus with the immune system.
    Curr Opin Immunol. 1994 Aug;6(4):560-3 PMID: 7946042
  79. Prevalence and activation phenotype of Sendai virus-specific CD4+ T cells.
    Virology. 1995 Jun 20;210(1):179-85 PMID: 7540783
  80. Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium.
    J Virol. 1996 Feb;70(2):1288-91 PMID: 8551597
  81. Cytokine production in the immune response to murine gammaherpesvirus 68.
    J Virol. 1996 May;70(5):3264-8 PMID: 8627809
  82. Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells.
    J Gen Virol. 1996 Apr;77 ( Pt 4):627-30 PMID: 8627250
  83. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes.
    J Immunol. 1996 Jul 15;157(2):822-6 PMID: 8752934
  84. Epstein-Barr virus and the B cell: that's all it takes.
    Trends Microbiol. 1996 May;4(5):204-8 PMID: 8727601
  85. Establishment and persistence of virus-specific CD4+ and CD8+ T cell memory.
    Immunol Rev. 1996 Apr;150:23-44 PMID: 8782700
  86. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68.
    J Virol. 1996 Oct;70(10):6775-80 PMID: 8794315
  87. Phenotypic analysis of antigen-specific T lymphocytes.
    Science. 1996 Oct 4;274(5284):94-6 PMID: 8810254
  88. Role of interferon-gamma in immunity to herpes simplex virus.
    J Leukoc Biol. 1996 Oct;60(4):528-32 PMID: 8864138
  89. Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity.
    Trends Microbiol. 1996 Oct;4(10):394-400 PMID: 8899965
  90. Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice.
    J Gen Virol. 1996 Nov;77 ( Pt 11):2819-25 PMID: 8922476
  91. Latent murine cytomegalovirus infection in macrophages.
    Virology. 1997 Jan 6;227(1):168-79 PMID: 9007070
  92. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.
    J Exp Med. 1996 Sep 1;184(3):863-71 PMID: 9064346
  93. Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68.
    J Virol. 1997 May;71(5):3916-21 PMID: 9094668
  94. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.
    Annu Rev Immunol. 1997;15:405-31 PMID: 9143694
  95. Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells.
    J Virol. 1997 Jun;71(6):4278-83 PMID: 9151815
  96. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen?
    J Exp Med. 1997 May 5;185(9):1641-50 PMID: 9151901
  97. Complete sequence and genomic analysis of murine gammaherpesvirus 68.
    J Virol. 1997 Aug;71(8):5894-904 PMID: 9223479
  98. EBV persistence in memory B cells in vivo.
    Immunity. 1998 Sep;9(3):395-404 PMID: 9768759
  99. Longitudinal analysis of the acute Sendai virus-specific CD4+ T cell response and memory.
    J Immunol. 1998 Nov 1;161(9):4530-5 PMID: 9794378
  100. Pathogenesis of murine gammaherpesvirus-68 infection in interleukin-6-deficient mice.
    Virology. 1998 Sep 30;249(2):359-66 PMID: 9791027
  101. Viral immune evasion due to persistence of activated T cells without effector function.
    J Exp Med. 1998 Dec 21;188(12):2205-13 PMID: 9858507
  102. Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo.
    J Virol. 1999 Feb;73(2):1075-9 PMID: 9882308
  103. Animal models of infection-mediated vasculitis.
    Curr Opin Rheumatol. 1999 Jan;11(1):17-23 PMID: 9894626
  104. Matching antibody class with pathogen type and portal of entry: cognate mechanisms regulate local isotype expression patterns in lymph nodes draining the respiratory tract of mice inoculated with respiratory viruses, according to virus replication competence and site of inoculation.
    J Immunol. 1997 Aug 15;159(4):1893-902 PMID: 9257854
  105. Primary structure of the alcelaphine herpesvirus 1 genome.
    J Virol. 1997 Sep;71(9):6517-25 PMID: 9261371
  106. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease.
    Nat Med. 1997 Dec;3(12):1346-53 PMID: 9396604
  107. Consequences of viral infections for lymphocyte compartmentalization and homeostasis.
    Semin Immunol. 1997 Dec;9(6):365-73 PMID: 9405265
  108. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.
    Immunol Rev. 1997 Oct;159:105-17 PMID: 9416506
  109. Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells.
    J Virol. 1998 Jan;72(1):882-5 PMID: 9420305
  110. Kinetic analysis of the specific host response to a murine gammaherpesvirus.
    J Virol. 1998 Feb;72(2):943-9 PMID: 9444986
  111. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
    J Immunol. 1998 Feb 15;160(4):1717-23 PMID: 9469429
Article Info
Journal
Philosophical transactions of the Royal Society of London. Series B, Biological sciences
Abbr.
Philos Trans R Soc Lond B Biol Sci
ISSN
0962-8436
Published
2001-04-29
Pages
581-93
Language
English
Region
England
NLM ID
7503623
PMCID
PMC1088446
Subset
IM
Grants
NIAID NIH HHS · AI29579 · United States
NCI NIH HHS · CA21765 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]